EU Says Ranbaxy India Site Safe, Despite FDA Warnings
European regulators on Thursday said a key Ranbaxy Laboratories Inc. site in India doesn't pose a risk to public health, just months after the U.S. Food and Drug Administration banned imports...To view the full article, register now.
Already a subscriber? Click here to view full article